The coronavirus disease (COVID-19) has created a serious health problem in pregnant people. We aimed to address whether vaccination can prevent development of placental disease in SARS-CoV-2 infected mothers.
METHODS:
We reported the pathology findings obtained from routine histopathological examination of placentas of overall 38 cases.
RESULTS:
We found low prevalence of placental pathology in vaccinated pregnant people with active SARS-CoV-2 infection in comparison to those unvaccinated cases.
CONCLUSION:
Based on our findings, SARS-CoV-2 vaccination can prevent development of placental pathological lesions and may lower the risk of serious illness in pregnant people.
GlynnSM, YangYJ, ThomasC, FriedlanderRL, CaginoKA, MatthewsKC, et al.SARS-CoV-2 and placental pathology: Malperfusion patterns are dependent on timing of infection during pregnancy. Am J Surg Pathol. 2022;46:51–7.
2.
BerteroL, BorellaF, BottaG, CarossoA, CosmaS, BovettiM, et al.Placenta histopathology in SARS-CoV-2 infection: Analysis of a consecutive series and comparison with control cohorts. Virchows Arch. 2021;479:715–28.
3.
Di GirolamoR, KhalilA, AlameddineS, D’AngeloE, GallianiC, MatarrelliB, et al.Placental histopathology after SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis. Am J Obstet Gynecol. MFM. 2021;3:100468.
4.
ShanesED, OteroS, MithalLB, MupanomundaCA, MillerES, GoldsteinJASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in pregnancy: Measures of immunity and placental histopathology. Obstet Gynecol. 2021;138:281–3.
5.
KhongTY, MooneyEE, ArielI, BalmusNC, BoydTK, BrundlerMA, et al.Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140:698–713.
